It’s not easy to transplant a whole human eye. The surgery is difficult. And the eyes themselves start to degenerate as soon as they’ve left the body. When surgeons attempted it a few years ago, the newly-transplanted eye wasn’t able to see. But researchers believe they might have a solution: a device that maintains and…
Inertia has signed three agreements with the Lawrence Livermore National Lab, paving the way for the company to bring its pioneering fusion reactor to market.
Many companies treat ESG as a compliance exercise, but when used correctly, it becomes a powerful tool for identifying risk and strengthening operations.